• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999 - 2018年美国慢性肾脏病患病率趋势

Trends in the prevalence of Chronic Kidney Disease in the United States, 1999-2018.

作者信息

Zhuang Mansi, Lv Xiaogang, Zhu Yanan, Zheng Nan, Zhan Yiqiang

机构信息

Department of Epidemiology, School of Public Health (Shenzhen), Sun Yat-sen University, Shenzhen, China.

Department of Health Education, Futian Institute of Health Education, Shenzhen, China.

出版信息

Front Med (Lausanne). 2025 Jan 15;11:1499225. doi: 10.3389/fmed.2024.1499225. eCollection 2024.

DOI:10.3389/fmed.2024.1499225
PMID:39882533
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11774909/
Abstract

BACKGROUND

Chronic Kidney Disease (CKD) is an escalating public health concern in the United States, linked with significant morbidity, mortality, and healthcare costs. Despite known risk factors like age, hypertension, and diabetes, comprehensive studies examining temporal trends in CKD prevalence are scarce. This study aims to analyze these trends using data from the National Health and Nutrition Examination Survey (NHANES).

METHODS

This cross-sectional study analyzed NHANES data spanning 20 years (1999-2018), including 55,081 adults aged 20 years and above. Key renal function indicators like estimated glomerular filtration rate (eGFR) and albumin-to-creatinine ratio (ACR) were assessed, and CKD stages were categorized accordingly.

RESULTS

A fluctuating trend in CKD prevalence was observed, with early CKD stages (G1-G3) increasing from 9.28% in 1999-2000 to 12.93% in 2017-2018. Advanced CKD stages (G4-G5) showed a slight increase in prevalence from 0.3% in 1999-2000 to 0.51% in 2017-2018. Notable disparities were observed across age groups, diabetes status, and racial categories. Relatively, the elderly, women, and non-Hispanic whites have a higher prevalence of CKD, while individuals with diabetes have a consistently higher prevalence of early CKD from 1999 to 2018. The increasing prevalence of diabetes during the study period highlights its significant role as a CKD risk factor.

CONCLUSION

The prevalence of CKD in the U.S. has been rising over the period 1999-2018, and varying across demographic groups, underscoring significant disparities and risk factors. These insights are crucial for healthcare planning, policy formulation, and targeted interventions for CKD management.

摘要

背景

慢性肾脏病(CKD)在美国已成为一个日益严重的公共卫生问题,与高发病率、死亡率及医疗费用相关。尽管已知年龄、高血压和糖尿病等风险因素,但对CKD患病率时间趋势进行全面研究的却很匮乏。本研究旨在利用美国国家健康与营养检查调查(NHANES)的数据来分析这些趋势。

方法

这项横断面研究分析了20年(1999 - 2018年)期间的NHANES数据,包括55081名20岁及以上的成年人。评估了诸如估算肾小球滤过率(eGFR)和白蛋白与肌酐比值(ACR)等关键肾功能指标,并据此对CKD分期进行分类。

结果

观察到CKD患病率呈波动趋势,早期CKD阶段(G1 - G3)从1999 - 2000年的9.28%升至2017 - 2018年的12.93%。晚期CKD阶段(G4 - G5)患病率从1999 - 2000年的0.3%略有升至2017 - 2018年的0.51%。在年龄组、糖尿病状态和种族类别方面观察到显著差异。相对而言,老年人、女性和非西班牙裔白人的CKD患病率较高,而糖尿病患者在1999年至2018年期间早期CKD的患病率一直较高。研究期间糖尿病患病率的上升凸显了其作为CKD风险因素的重要作用。

结论

1999 - 2018年期间美国CKD患病率一直在上升,且在不同人群中存在差异,突出了显著的差异和风险因素。这些见解对于医疗保健规划、政策制定以及针对CKD管理的靶向干预至关重要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/124024b4d9c3/fmed-11-1499225-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/4bf731590e5b/fmed-11-1499225-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/5c8559a66f04/fmed-11-1499225-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/124024b4d9c3/fmed-11-1499225-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/4bf731590e5b/fmed-11-1499225-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/5c8559a66f04/fmed-11-1499225-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dcc9/11774909/124024b4d9c3/fmed-11-1499225-g0003.jpg

相似文献

1
Trends in the prevalence of Chronic Kidney Disease in the United States, 1999-2018.1999 - 2018年美国慢性肾脏病患病率趋势
Front Med (Lausanne). 2025 Jan 15;11:1499225. doi: 10.3389/fmed.2024.1499225. eCollection 2024.
2
Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018.美国成年人慢性肾脏病知晓率的性别差异,1999 年至 2018 年。
PLoS One. 2020 Dec 18;15(12):e0243431. doi: 10.1371/journal.pone.0243431. eCollection 2020.
3
Trends in Prevalence of Chronic Kidney Disease in the United States.美国慢性肾脏病患病率的趋势
Ann Intern Med. 2016 Oct 4;165(7):473-481. doi: 10.7326/M16-0273. Epub 2016 Aug 2.
4
Chronic kidney disease, physical activity and cognitive function in older adults-results from the National Health and Nutrition Examination Survey (2011-2014).慢性肾脏病、老年人的体力活动与认知功能——来自全国健康和营养调查(2011-2014 年)的结果。
Nephrol Dial Transplant. 2022 Oct 19;37(11):2180-2189. doi: 10.1093/ndt/gfab338.
5
Use of Statins for Primary Prevention Among Individuals With CKD in the United States: A Cross-Sectional, Time-Trend Analysis.美国慢性肾脏病患者中他汀类药物用于一级预防的情况:一项横断面时间趋势分析
Am J Kidney Dis. 2025 Apr;85(4):421-431.e1. doi: 10.1053/j.ajkd.2024.11.003. Epub 2024 Dec 31.
6
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.筛查的高危志愿者和普通人群中的慢性肾脏病与心血管疾病:肾脏早期评估项目(KEEP)及1999 - 2004年国家健康与营养检查调查(NHANES)
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.
7
Asian Americans & chronic kidney disease in a nationally representative cohort.亚裔美国人与全国代表性队列中的慢性肾脏病。
BMC Nephrol. 2019 Jan 9;20(1):10. doi: 10.1186/s12882-018-1145-5.
8
CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES).利用基于人群的国家健康和营养检查调查(NHANES)的实验室数据进行慢性肾脏病监测。
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S46-55. doi: 10.1053/j.ajkd.2008.07.054.
9
Prevalence and trends of chronic kidney disease and its risk factors among US adults: An analysis of NHANES 2003-18.美国成年人慢性肾脏病及其危险因素的患病率和趋势:对2003 - 2018年美国国家健康与营养检查调查(NHANES)的分析
Prev Med Rep. 2020 Sep 1;20:101193. doi: 10.1016/j.pmedr.2020.101193. eCollection 2020 Dec.
10
State-Level Awareness of Chronic Kidney Disease in the U.S.美国各州对慢性肾脏病的认知程度
Am J Prev Med. 2017 Sep;53(3):300-307. doi: 10.1016/j.amepre.2017.02.015. Epub 2017 Apr 11.

本文引用的文献

1
Gender disparities in utilization of statins for low density lipoprotein management across the spectrum of atherosclerotic cardiovascular disease: Insights from the houston methodist cardiovascular disease learning health system registry.在整个动脉粥样硬化性心血管疾病范围内,他汀类药物用于低密度脂蛋白管理的性别差异:来自休斯顿卫理公会心血管疾病学习健康系统登记处的见解。
Am J Prev Cardiol. 2024 Aug 14;19:100722. doi: 10.1016/j.ajpc.2024.100722. eCollection 2024 Sep.
2
Chronic kidney disease and the global public health agenda: an international consensus.慢性肾脏病与全球公共卫生议程:国际共识。
Nat Rev Nephrol. 2024 Jul;20(7):473-485. doi: 10.1038/s41581-024-00820-6. Epub 2024 Apr 3.
3
Association of the dietary inflammation index (DII) with the prevalence of chronic kidney disease in patients with type-2 diabetes mellitus.
饮食炎症指数(DII)与 2 型糖尿病患者慢性肾脏病患病率的相关性。
Ren Fail. 2023;45(2):2277828. doi: 10.1080/0886022X.2023.2277828. Epub 2023 Nov 23.
4
Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.2 型糖尿病继发 3a 期慢性肾脏病合并多种疾病与白蛋白尿状况在伦敦西北部多民族人群中的相关性及其进展:一项真实世界研究。
PLoS One. 2023 Aug 25;18(8):e0289838. doi: 10.1371/journal.pone.0289838. eCollection 2023.
5
Interdisciplinary Telehealth Team Positively Impacts Difficult-to-Control Hypertension in CKD.多学科远程医疗团队积极改善慢性肾脏病中难以控制的高血压。
Kidney360. 2023 Jun 1;4(6):e817-e823. doi: 10.34067/KID.0000000000000130. Epub 2023 Apr 17.
6
A Study on CKD Progression and Health Disparities Using System Dynamics Modeling.一项使用系统动力学模型对慢性肾脏病进展和健康差异的研究。
Healthcare (Basel). 2022 Aug 26;10(9):1628. doi: 10.3390/healthcare10091628.
7
Racial and Sex Disparities in Gout Prevalence Among US Adults.美国成年人痛风患病率的种族和性别差异。
JAMA Netw Open. 2022 Aug 1;5(8):e2226804. doi: 10.1001/jamanetworkopen.2022.26804.
8
Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care.瑞典和美国常规护理中慢性肾病成人使用肾毒性药物的情况。
Clin Kidney J. 2021 Oct 29;15(3):442-451. doi: 10.1093/ckj/sfab210. eCollection 2022 Mar.
9
Prevalence of chronic kidney disease in Asia: a systematic review and analysis.亚洲慢性肾脏病的患病率:一项系统评价和分析。
BMJ Glob Health. 2022 Jan;7(1). doi: 10.1136/bmjgh-2021-007525.
10
Association of metabolic dysfunction-associated fatty liver disease with kidney disease.代谢功能障碍相关脂肪性肝病与肾脏疾病的关联
Nat Rev Nephrol. 2022 Apr;18(4):259-268. doi: 10.1038/s41581-021-00519-y. Epub 2022 Jan 10.